PAVmed Inc. (PAVM)

PAVmed Statistics

Total Valuation

PAVmed has a market cap or net worth of $10.93 million. The enterprise value is $92.02 million.

Market Cap	10.93M
Enterprise Value	92.02M

Important Dates

The next confirmed earnings date is Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

PAVmed has 10.41 million shares outstanding. The number of shares has increased by 30.10% in one year.

Shares Outstanding	10.41M
Shares Change (YoY)	+30.10%
Shares Change (QoQ)	+5.27%
Owned by Insiders (%)	14.12%
Owned by Institutions (%)	13.83%
Float	8.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	1.35
PS Ratio	2.29
Forward PS	3.45
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	24.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.57

Current Ratio	0.57
Quick Ratio	0.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-292.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-80.07%
Return on Capital (ROIC)	-94.71%
Revenue Per Employee	$35,785
Profits Per Employee	-$629,430
Employee Count	107
Asset Turnover	0.08
Inventory Turnover	11.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.48% in the last 52 weeks. The beta is 0.69, so PAVmed's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-73.48%
50-Day Moving Average	1.21
200-Day Moving Average	1.53
Relative Strength Index (RSI)	44.51
Average Volume (20 Days)	25,938

Short Selling Information

The latest short interest is 277,057, so 2.66% of the outstanding shares have been sold short.

Short Interest	277,057
Short Previous Month	270,430
Short % of Shares Out	2.66%
Short % of Float	3.10%
Short Ratio (days to cover)	6.66

Income Statement

In the last 12 months, PAVmed had revenue of $3.83 million and -$67.35 million in losses. Loss per share was -$8.08.

Revenue	3.83M
Gross Profit	-2.97M
Operating Income	-59.63M
Pretax Income	-61.46M
Net Income	-67.35M
EBITDA	-57.28M
EBIT	-59.63M
Loss Per Share	-$8.08

Balance Sheet

The company has $27.40 million in cash and $50.03 million in debt, giving a net cash position of -$22.64 million or -$2.18 per share.

Cash & Cash Equivalents	27.40M
Total Debt	50.03M
Net Cash	-22.64M
Net Cash Per Share	-$2.18
Equity (Book Value)	-18.64M
Book Value Per Share	-7.70
Working Capital	-23.18M

Cash Flow

In the last 12 months, operating cash flow was -$47.73 million and capital expenditures -$246,000, giving a free cash flow of -$47.97 million.

Operating Cash Flow	-47.73M
Capital Expenditures	-246,000
Free Cash Flow	-47.97M
FCF Per Share	-$4.61

Margins

Gross Margin	-77.62%
Operating Margin	-1,557.40%
Pretax Margin	-1,895.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,628.51%

Dividends & Yields

PAVmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.10%
Shareholder Yield	-30.10%
Earnings Yield	-616.37%
FCF Yield	-439.05%

Analyst Forecast

The average price target for PAVmed is $21.00, which is 1,900.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	1,900.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	150.81%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 7, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Dec 7, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

PAVmed has an Altman Z-Score of -16.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.72
Piotroski F-Score	3